PEB

Paul Edward Bottinelli III Portfolio

Invests via Boone Capital Management LLC | Managed by Paul Edward Bottinelli III, Daniel Walter Boone
Invests via Boone Capital Management LLC
Managed by Paul Edward Bottinelli III, Daniel Walter Boone
Automatically Tracked
Tracking: 0 Updated: Jun 12 at 08:02 PM
Paul Edward Bottinelli III Profile

With a robust background in corporate finance and strategic development, Paul Edward Bottinelli III stands out as a seasoned executive with considerable expertise. His experience spans across multiple sectors, where he has consistently demonstrated his acumen in driving growth and innovation. Having held various leadership roles, he is recognized for fostering collaboration among diverse stakeholders to unlock value. This blend of operational insight and investment knowledge positions him as an influential figure within capital markets. With a keen focus on market dynamics and organizational performance, he contributes significantly to shaping business strategies that align with evolving industry trends.

With a robust background in corporate finance and strategic development, Paul Edward Bottinelli III stands out as a seasoned executive with considerable expertise. His experience spans across multiple sectors, where he has consistently demonstrated his acumen in driving growth and innovation. Having held various leadership roles, he is recognized for fostering collaboration among diverse stakeholders to unlock value. This blend of operational insight and investment knowledge positions him as an influential figure within capital markets. With a keen focus on market dynamics and organizational performance, he contributes significantly to shaping business strategies that align with evolving industry trends.

Investment Philosophy & Strategy

Growth opportunities abound in industries ripe for transformation. Paul Edward Bottinelli III leverages his extensive corporate finance background to identify and capitalize on emerging market trends. His strategic approach prioritizes innovation, fostering collaboration among diverse teams to enhance operational efficiency and drive value creation. This methodical focus enables a keen understanding of competitive positioning and sector dynamics, allowing him to guide investments toward high-potential ventures effectively. By maintaining an agile mindset toward capital allocation, he optimally positions his engagements within dynamic markets that favor both sustainable growth and impactful disruption.

Growth opportunities abound in industries ripe for transformation. Paul Edward Bottinelli III leverages his extensive corporate finance background to identify and capitalize on emerging market trends. His strategic approach prioritizes innovation, fostering collaboration among diverse teams to enhance operational efficiency and drive value creation. This methodical focus enables a keen understanding of competitive positioning and sector dynamics, allowing him to guide investments toward high-potential ventures effectively. By maintaining an agile mindset toward capital allocation, he optimally positions his engagements within dynamic markets that favor both sustainable growth and impactful disruption.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
55.64%
Gain +0.23%
Monthly
1.12%
Yearly
14.26%
Drawdown
13.01%
$356.53M
Equity
Holdings
$356.53M
Investment
$299.43M
$149.07M
Profit +$851,077.01
Realized
$91.97M
Unrealized
$57.1M
Dividends
$11.3M

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.23%
Profit
$851,077.01
Win %
66%
This Week
Compared To Last Week
Gain
2.61%
Profit
$9.08M
Win %
66%
This Month
Compared to last month
Gain
2.35%
Profit
$8.2M
Win %
66%
This Year
Compared to last year
Gain
-32.29%
Profit
-$90.99M
Win %
72%
Tenax Therapeutics Inc. logo
TENX Tenax Therapeutics Inc.
+6.99%
+$150,000
The Cigna Group logo
CI The Cigna Group
+1.12%
+$455,197.82
Teleflex Incorporated logo
TFX Teleflex Incorporated
+0.97%
+$348,490
Biomarin Pharmaceutical Inc. logo
BMRN Biomarin Pharmaceutical Inc.
+0.73%
+$221,887.76
UnitedHealth Group Incorporated logo
UNH UnitedHealth Group Incorporated
+0.72%
+$232,924.44
Kodiak Sciences Inc. logo
KOD Kodiak Sciences Inc.
+0.27%
+$25,319.88
Guardian Pharmacy Services Inc. logo
GRDN Guardian Pharmacy Services Inc.
+0.05%
+$12,623.86
logo
AZN
0%
$0
BridgeBio Pharma, Inc. logo
BBIO BridgeBio Pharma, Inc.
-1.11%
-$171,621.75
Ionis Pharmaceuticals, Inc. logo
IONS Ionis Pharmaceuticals, Inc.
-0.74%
-$272,784.49
Mirum Pharmaceuticals Inc. logo
MIRM Mirum Pharmaceuticals Inc.
-0.2%
-$82,141.02
Medtronic plc logo
MDT Medtronic plc
-0.19%
-$59,709.75
Avanos Medical Inc. logo
AVNS Avanos Medical Inc.
-0.04%
-$11,849.09
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
196
Longs Won
109/196 55%
Profit Factor
3.31
Profitability
Shorts Won
0/0 0%
Standard Deviation
$2.32M
Average Win
$1.96M
Best Trade
(Jun 10) $13.06M
Sharpe Ratio
-15.86
Average Loss
-$741,328.18
Worst Trade
(Mar 30) -$7.3M
Z-Score
-0.91 (63.66%)
Commissions
$0
Avg. Trade Length
10m 2w 2d
Expectancy
$760,552.06
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01%
Consecutive Losing Trades 481 433 385 337 289 241 192 144 96 48
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV